Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 125Lung Neoplasms 50Triple Negative Breast Neoplasms 35Breast Neoplasms 33Small Cell Lung Carcinoma 30Ovarian Neoplasms 26Squamous Cell Carcinoma of Head and Neck 25Neoplasm Metastasis 21Endometrial Neoplasms 20Fallopian Tube Neoplasms 19Neoplasms 16Parkinson Disease 4, Autosomal Dominant Lewy Body 15Head and Neck Neoplasms 12Colorectal Neoplasms 11Carcinoma 10Prostatic Neoplasms 9Oropharyngeal Neoplasms 9Esophageal Neoplasms 9Urinary Bladder Neoplasms 8Carcinoma, Transitional Cell 8Pancreatic Neoplasms 7Carcinoma, Squamous Cell 7Laryngeal Neoplasms 6Carcinoma, Ovarian Epithelial 6Adenocarcinoma of Lung 6Uterine Cervical Neoplasms 5Mouth Neoplasms 5Mesothelioma 5Lung Diseases 5Stomach Neoplasms 4

Interventions

pembrolizumab 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Solid Tumor × Carboplatin × 90 days × Clear all
NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡